Jonathan Sheena - Aug 30, 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director, CO-FOUNDER
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Aug 30, 2021
Transactions value $
-$1,993,745
Form type
4
Date filed
9/1/2021, 09:06 PM
Previous filing
Jul 26, 2021
Next filing
Sep 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $1.67K +310 +0.07% $5.40* 456K Aug 30, 2021 Direct
transaction NTRA Common Stock Options Exercise $1.61K +168 +0.04% $9.59* 456K Aug 30, 2021 Direct
transaction NTRA Common Stock Options Exercise $19.8K +1.9K +0.42% $10.41* 458K Aug 30, 2021 Direct
transaction NTRA Common Stock Options Exercise $18K +1.94K +0.42% $9.29* 460K Aug 30, 2021 Direct
transaction NTRA Common Stock Sale -$524K -4.32K -0.94% $121.36 456K Aug 30, 2021 Direct F1, F2
transaction NTRA Common Stock Options Exercise $5.49K +1.02K +0.22% $5.40* 457K Sep 1, 2021 Direct
transaction NTRA Common Stock Options Exercise $5.29K +552 +0.12% $9.59* 457K Sep 1, 2021 Direct
transaction NTRA Commom Stock Options Exercise $68.1K +6.55K +1.43% $10.41* 464K Sep 1, 2021 Direct
transaction NTRA Common Stock Options Exercise $50.4K +5.42K +1.17% $9.29* 469K Sep 1, 2021 Direct
transaction NTRA Common Stock Sale -$1.64M -13.5K -2.89% $121.12 456K Sep 1, 2021 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -310 -23.34% $0.00 1.02K Aug 30, 2021 Common Stock 310 $5.40 Direct F5
transaction NTRA Stock Option (right to buy) Options Exercise $0 -168 -0.42% $0.00 40.2K Aug 30, 2021 Common Stock 168 $9.59 Direct F6
transaction NTRA Stock Option (right to buy) Options Exercise $0 -1.9K -5.39% $0.00 33.4K Aug 30, 2021 Common Stock 1.9K $10.41 Direct F7
transaction NTRA Stock Option (right to buy) Options Exercise $0 -1.94K -11.2% $0.00 15.4K Aug 30, 2021 Common Stock 1.94K $9.29 Direct F8
transaction NTRA Stock Option (right to buy) Options Exercise $0 -1.02K -100% $0.00* 0 Sep 1, 2021 Common Stock 1.02K $5.40 Direct F5
transaction NTRA Stock Option (right to buy) Options Exercise $0 -552 -1.37% $0.00 39.6K Sep 1, 2021 Common Stock 552 $9.59 Direct F6
transaction NTRA Stock Option (right to buy) Options Exercise $0 -6.55K -19.61% $0.00 26.8K Sep 1, 2021 Common Stock 6.55K $10.41 Direct F7
transaction NTRA Stock Option (right to buy) Options Exercise $0 -5.42K -35.21% $0.00 9.98K Sep 1, 2021 Common Stock 5.42K $9.29 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expires on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
F5 The option shares vested fully and became exercisable on November 20, 2019.
F6 The option shares vested fully and became exercisable on April 1, 2020.
F7 The option shares vested fully and became exercisable on March 21, 2021.
F8 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.